Clair Health
Pioneering continuous hormone intelligence.
San Francisco, United States · Founded 2025 · $11.6M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2C
- Website
- wearclair.com
- Total Funding
- $11.6M
- Last Round
- $11.6M SeedJun 2026
- Rounds
- 1
About
Clair Health is a San Francisco-based women's health startup building the world's first noninvasive continuous hormone monitor, a wrist-worn wearable device that tracks estrogen, progesterone, LH, FSH, and PdG in real-time. Founded in 2025 by Stanford graduates Jenny Duan (CEO) and Abhinav Agarwal, Clair uses 10 biosensors and over 130 proprietary biomarkers to give women continuous, on-device hormone intelligence without needles or test strips. In June 2026, the company raised $11.6 million in seed funding led by Khosla Ventures to advance clinical validation and bring the device to market.
Summary
Clair Health is a Biotech company based in San Francisco, United States, founded in 2025. It has raised $11.6M in total across 1 round, most recently a $11.6M Seed round in Jun 2026. Investors include Khosla Ventures, Reach Capital and Anne Wojcicki.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2026
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
